Concurrent/adjuvant cisplatin-based chemoradiotherapy is regarded as the standard of
treatment for locoregionally advanced nasopharyngeal carcinoma (NPC). However, patients …

Objectives/Hypothesis Bone marrow stromal cell antigen 2 (BST2) was one of the proteins
that were found to be related to tumor metastasis in our previous proteomic study. Now we …

Background Drug resistance limits the treatment effect of cisplatin-based chemotherapy in
head and neck squamous cell carcinoma (HNSCC), and the underlying mechanism is not …

Nasopharyngeal carcinoma (NPC) is a rare cancer in most parts of the world, but is
prevalent in South China area. Besides, therapeutic outcome is still unsatisfactory for …

Nasopharyngeal carcinoma (NPC) can develop cisplatin‐resistant phenotype. Research
has revealed that enriched in cancer stem cell population is involved in developing cisplatin …

Despite recent in advances in the management of nasopharyngeal carcinoma (NPC),
development of targeted therapy remains challenging particularly in patients with recurrent …

Recurrent/metastatic nasopharyngeal carcinoma (NPC) is known for having a poor
prognosis due to its unfavorable response to chemoradiotherapy. However, the specific …

Abstract C-terminal binding protein‑2 (CtBP2) is a transcriptional co-repressor that is
associated with tumorigenesis and tumor progression. It has been reported to predict a poor …

Oral squamous cell carcinoma (OSCC) is one of the main types of head and neck squamous
cell carcinoma. Although progress has been made in treating OSCC, it remains a threat to …

Purpose Thrombospondin 1 (THBS1) is an endogenous inhibitor of angiogenesis, but it also
promotes tumor invasion, metastasis, and immune response in the tumor environment …